Quality control for translational biomedical informatics
by Moffitt, Richard Austin, Ph.D., GEORGIA INSTITUTE OF TECHNOLOGY, 2010, 154 pages; 3425126

Abstract:

Translational biomedical informatics is the application of computational methods to facilitate the translation of basic biomedical science to clinical relevance. An example of this is the multi-step process in which large-scale microarray-based discovery experiments are refined into reliable clinical diagnostic tests.

The quality of microarray data is a major issue that must be addressed before microarrays can reach their full potential as a clinical molecular profiling tool for personalized and predictive medicine. The FDA has completed phase-I of the MicroArray Quality Control (MAQC) project, and is currently developing guidelines and standards on microarray data reporting, quality control, and data analysis [1]. The current status of microarray quality control (QC) and noise reduction however, is still a controversial collection of tools and methods. While competing model-based tools such as dChip [2, 3], MAS5.0 [4], RMA [5, 6], and PLIER [7] have been developed to improve the quality of microarray gene expression data, these tools fall short in two important areas (1) they do not incorporate adequate spatial information into the outlier detection methods and (2) they do not incorporate outlier information into their normalization routines. The methodology discussed in this dissertation, called caCORRECT, addresses these deficiencies and seeks to replace or augment existing technologies in order to improve the translation of microarray data to clinical relevance [8-12].

As a case study to validate and demonstrate the usefulness of caCORRECT, the entire workflow of biomarker discovery was executed for the clinical problem of classifying Renal Cell Carcinoma (RCC) specimens into appropriate subtypes [13, 14]. Two biomarkers are discovered, NNMT and PRKAB1, which are able to separate the chromophobe and clear cell subtypes of RCC with perfect accuracy for all of the samples tested. To translate this discovery into a clinically relevant test, improvements are made to the reliability of quantum dot based immunohistochemistry [15, 16].

 
AdviserMay D. Wang
SchoolGEORGIA INSTITUTE OF TECHNOLOGY
SourceDAI/B 71-10, p. , Oct 2010
Source TypeDissertation
SubjectsBiomedical engineering; Bioinformatics
Publication Number3425126
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3425126
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.